ETHICAL COMPLIANCE REPORT

J B CHEMICALS AND PHARMA

Sector:

Healthcare

Industry:

Drug Manufacturers - Specialty & Generic

Overall Compliance

compliant

PRIMARY BUSINESS FILTER
Pharmaceutical
compliant
REVENUE RATIO FILTER
0%
View Calculations
DEBT RATIO FILTER
8.9%
View Calculations
LIQUIDITY RATIO FILTER
2.4%
View Calculations

Revenue Ratio

The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.

Non Compliant

Questionable

Compliant

CALCULATION

\textbf{Revenue Ratio:} \\[12pt] \dfrac{0.00}{34863422000.00} \times 100 = 0.00\%

FORMULA

\textbf{Revenue Ratio:} \\[12pt] \dfrac{\text{Unethical Segments}}{\text{Total Revenue}} \times 100 \; \leq \; 3\%

Segment	Compliance	Value
Sale of Pharmaceuticals Products	compliant	₹3,436.27
Product Development Services	compliant	₹11.40
Realised Exchange Differences on Sale of Products and Services	compliant	₹1.41
Miscellaneous income	compliant	₹0.10
Other Income	compliant	₹37.17

Debt Ratio

The interest bearing debt should not exceed 31% of the total assets. This is to ensure that the company is not paying a significant portion of its assets as interest.

8.9%

CALCULATION

\textbf{Debt Ratio:} \\[12pt] \dfrac{3571407000.00}{39941300000.00} \times 100 = 8.90\%

FORMULA

\textbf{Debt Ratio:} \\[12pt] \dfrac{\text{Interest Bearing Debt}}{\text{Total Assets}} \times 100 \; \leq \; 30\%

Liquidity Ratio

The total liquid assets should not exceed 90% of the total assets. This is to ensure that trading this stock does not become similar to trading a currency.

2.4%

CALCULATION

\textbf{Liquidity Ratio:} \\[12pt] \dfrac{955384000.00}{39941300000.00} \times 100 = 2.40\%

FORMULA

\textbf{Liquidity Ratio:} \\[12pt] \dfrac{\text{Total Liquid Assets}}{\text{Total Assets}} \times 100 \; \leq \; 90\%